Skip to content

Demonstration of the application of artificial intelligence-based diabetic retinopathy screening technology

Demonstration of the application of artificial intelligence-based diabetic retinopathy screening technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096569
Enrollment
Unknown
Registered
2025-01-26
Start date
2022-11-04
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

DR Group and non-DR group:none

Sponsors

Shenzhen Luohu District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with type 1 and type 2 diabetes, normal population, and pre-diabetes (fasting blood glucose between 6.1 and 7.0mmol/L or OGTT two-hour blood glucose between 7.8 and 11.1mmol/L) who are 18 to 80 years old (capable of understanding and signing informed consent) and managed by the community for chronic disease.

Exclusion criteria

Exclusion criteria: Brain disorders, history of fundus retinal surgery, and eye diseases that affect the quality of fundus imaging (such as cataracts, vitreous opacity).

Design outcomes

Primary

MeasureTime frame
body mass index;

Secondary

MeasureTime frame
waist;weight;

Countries

China

Contacts

Public ContactBing Liu

Shenzhen Luohu District People's Hospital

liu6bing@163.com+86 185 0532 1056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026